Overview

Benzydamine in Sore Throat Pain Relief (BePaiR Study)

Status:
Completed

Trial end date:
2021-06-30

Target enrollment:

Participant gender:

Summary

The aim of this study is to generate new clinical data about the speed of relief provided by a single application of Benzydamine hydrochloride 0,3% oromucosal spray vs Benzydamine hydrochloride 3 mg lozenges mint flavour.

Phase:

Phase 4

Details

Lead Sponsor:

Aziende Chimiche Riunite Angelini Francesco S.p.A

Collaborator:

Zak-Pharma Dienstleistung Ges.m.b.H.

Treatments:

Benzydamine